Skip to Content
Merck
CN

764582

Polyethylenimine, linear

average Mn 5,000, PDI ≤1.3

Synonym(s):

PEI

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
(CH2CH2NH)n
CAS Number:
MDL number:
UNSPSC Code:
12162002
NACRES:
NA.23
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

solid

Quality Level

mol wt

average Mn 5,000

mp

54-59 °C

PDI

≤1.3

storage temp.

2-8°C

SMILES string

N1CC1

InChI

1S/C2H5N/c1-2-3-1/h3H,1-2H2

InChI key

NOWKCMXCCJGMRR-UHFFFAOYSA-N

General description

All polyethylene imine polymers are hydrophilic and may contain approx. 30% hydrated water.


Still not finding the right product?

Explore all of our products under Polyethylenimine, linear


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2

Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Articles

Delivery of Nucleic Acids Using Polymers

Microparticles in drug delivery: Study on controlling chitosan microparticle size and distribution, exploring encapsulation of BSA and TPP cross-linker.

Gene therapy has become one of the most discussed techniques in biomedical research in recent years.

View All Articles

Prashanth K B Nagesh et al.
Cancers, 10(9) (2018-08-29)
The therapeutic application of microRNA(s) in the field of cancer has generated significant attention in research. Previous studies have shown that miR-205 negatively regulates prostate cancer cell proliferation, metastasis, and drug resistance. However, the delivery of miR-205 is an unmet
Laura R H Ip et al.
Oncotarget, 6(12), 10548-10562 (2015-04-15)
Treatment options for ovarian cancer patients remain limited and overall survival is less than 50% despite recent clinical advances. The lipid phosphatase inositol polyphosphate 4-phosphatase type II (INPP4B) has been described as a tumor suppressor in the PI3K/Akt pathway with



Global Trade Item Number

SKUGTIN
764582-1G04061832923048